GlassScriptPhysician profile
Eirene G John
NPI 1639514169
$282.73
in general payments reported to CMS, 2019-2025
11 companies · $18.99 in 2025
The $18.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2020: $89.00 · 2021: $43.71 · 2022: $16.30 · 2023: $82.73 · 2024: $17.00 · 2025: $18.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $81.62 | 2019-2025 | Shingrix, Arexvy |
| Sanofi Pasteur INC. | $57.50 | 2020 | |
| Abbott Laboratories | $20.59 | 2023 | Freestyle Libre 2 |
| Abbvie INC. | $16.90 | 2023 | |
| Novartis Pharmaceuticals Corporation | $16.30 | 2022 | |
| Pfizer INC. | $15.61 | 2023 | |
| Lilly USA, LLC | $15.50 | 2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2020 | |
| Novo Nordisk INC | $15.00 | 2021 | |
| Dynavax Technologies Corporation | $14.71 | 2021 | |
| Grifols USA, LLC | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eirene John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.